HALOPERIDOL REDUCTION CAN BE ASSAYED IN HUMAN RED-BLOOD-CELLS

被引：37

作者：

INABA, T

KALOW, W

SOMEYA, T

TAKAHASHI, S

CHEUNG, SW

TANG, SW

机构：

[1] SHIGA UNIV MED SCI,DEPT PSYCHIAT,OTSU,SHIGA 52021,JAPAN

[2] CLARKE INST PSYCHIAT,PSYCHOPHARMACOL UNIT,TORONTO M5T 1R8,ONTARIO,CANADA

来源：

关键词：

D O I：

10.1139/y89-237

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1468 / 1469

页数：2

共 15 条

[1] ALTAMURA C, 1988, PROG NEURO-PSYCHOPH, V12, P689
[2] QUANTIFICATION OF REDUCED HALOPERIDOL AND HALOPERIDOL BY RADIOIMMUNOASSAY
BROWNING, JL
HARRINGTON, CA
DAVIS, CM
[J]. JOURNAL OF IMMUNOASSAY, 1985, 6 (1-2): : 45 - 66
[3] CHANG WH, 1987, BIOL PSYCHIAT, V22, P1406
[4] CHANG WH, 1989, BIOL PSYCHIAT, V26, P239
[5] ERESHEFSKY L, 1984, J CLIN PSYCHOPHARM, V4, P138
[6] REVERSED-PHASE LIQUID-CHROMATOGRAPHY FOR THE SEPARATION OF CHLORPROMAZINE, IMIPRAMINE AND SOME OF THEIR METABOLITES
FEKETE, J
DELCASTILHO, P
KRAAK, JC
[J]. JOURNAL OF CHROMATOGRAPHY, 1981, 204 (JAN): : 319 - 327
[7] FORSMAN A, 1978, CURR THER RES CLIN E, V24, P567
[8] INABA T, 1989, DRUG METAB DISPOS, V17, P330
[9] SERUM LEVEL OF HALOPERIDOL AND ITS CLINICAL-SIGNIFICANCE
ITOH, H
YAGI, G
OHTSUKA, N
IWAMURA, K
ICHIKAWA, K
[J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY, 1980, 4 (02): : 171 - 183
[10] KO GN, 1989, J CLIN PSYCHOPHARM, V9, P186